过去一年中添加的文章，按日期排序
[HTML][HTML] New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
15 天前 - … weight loss. From a mechanistic standpoint, it is important to note that hepatocytes,
stellate cells, and Kupffer cells do not possess the classical GLP-1 receptors. Therefore, the …
stellate cells, and Kupffer cells do not possess the classical GLP-1 receptors. Therefore, the …
Prevalence of genitourinary symptoms in people with type 2 diabetes initiated with SGLT2 inhibitors
V Viswanathan, D Samraj, L Baid… - International Journal of …, 2024 - Springer
30 天前 - … can also reduce blood pressure and result in weight loss. In spite of the benefits
of this … In our study, dapagliflozin was the most commonly used SGLT2 inhibitors with 68.8%, …
of this … In our study, dapagliflozin was the most commonly used SGLT2 inhibitors with 68.8%, …
Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction
38 天前 - … We found that weight loss with dapagliflozin was predominantly related to decreases
in body fat, primarily driven by reductions in android and trunk fat, and these changes …
in body fat, primarily driven by reductions in android and trunk fat, and these changes …
301-OR: Synergistic Effects of Dapagliflozin and Tirzepatide Combination Treatment on Weight Loss and Glucose Regulation in Diet-Induced Obese Animals
M ABU-FARHA, I AL-KHAIRI, M QADDOUMI… - Diabetes, 2024 - Am Diabetes Assoc
41 天前 - … improvements in weight loss as well as their glycemic control. … treated with either
placebo, 100 nmole/kg Tirzepatide, Dapagliflozin 1mg/kg or a combination of Dapagliflozin …
placebo, 100 nmole/kg Tirzepatide, Dapagliflozin 1mg/kg or a combination of Dapagliflozin …
1682-P: Weight Endpoints in Randomized Controlled Trials (Rcts) of Adults Eligible for Antiobesity Medications (AOM)—A Systematic Literature Review (SLR)
A BJORNSON, MM GARDNER, BMK DONATO… - Diabetes, 2024 - Am Diabetes Assoc
41 天前 - … Conclusions: Emerging pharmacotherapies are showing longer term and greater
weight loss. While data on WC was less frequently reported, it can provide important insights …
weight loss. While data on WC was less frequently reported, it can provide important insights …
908-P: Use of DPP4i/SGLT2i Fixed Dose Combinations in Indian Clinical Practice—A KAP Survey
B SABOO, CM PRAJAPATI, PA SHETTY… - Diabetes, 2024 - Am Diabetes Assoc
41 天前 - … Also 60.5% (n=112) physicians favored DPP4i/SGLT2i FDC for all 4 given
reasons ie CV benefits, lower hypoglycemia risk, weight loss promotion & targeting multiple …
reasons ie CV benefits, lower hypoglycemia risk, weight loss promotion & targeting multiple …
# 1311 Cardiac damage in a multifactorial DKD/CKD mouse model resembles HFpEF and can be reduced by standard-of-care treatment
A van Koppen, E Pieterman, S Hinke… - Nephrology Dialysis …, 2024 - academic.oup.com
63 天前 - … Combination therapy with Lisinopril and Dapagliflozin reduced cardiac weight and
cardiac fibrosis. This indicates cardiac involvement in the DKD mouse model which confirms …
cardiac fibrosis. This indicates cardiac involvement in the DKD mouse model which confirms …
# 1870 Uninephrectomized diabetic rats delay onset of hyperglycemia via down-regulation of SGLT2 mRNA
Y Ishizaki, M Kikuchi, S Fujimoto… - Nephrology Dialysis …, 2024 - academic.oup.com
63 天前 - … Only the Sham + placebo group showed increased urinary volume and weight
loss after week 10 due to hyperglycemia. There were no significant differences in serum …
loss after week 10 due to hyperglycemia. There were no significant differences in serum …
# 1299 The SGLT2 inhibitor canagliflozin, but not dapagliflozin or empagliflozin, ameliorates vascular calcification in a mouse model of nephrocalcinosis
L Fernandez, M Brunet, M Buleon… - Nephrology Dialysis …, 2024 - academic.oup.com
63 天前 - … of urinary sodium and glucose excretion and weight loss, recent studies have also
reported direct … and dapagliflozin) could reduce the development of vascular calcification. …
reported direct … and dapagliflozin) could reduce the development of vascular calcification. …
Idiopathic nodular glomerulosclerosis: a case report
C Landry, A Rodriguez-Calero, B Vogt… - Frontiers in medicine, 2024 - frontiersin.org
80 天前 - … -2 receptor antagonist and dapagliflozin, resulting in … of smoking and efforts toward
weight loss, are strongly advised. … treatment involving olmesartan and dapagliflozin was …
weight loss, are strongly advised. … treatment involving olmesartan and dapagliflozin was …